ADAM10 and early-onset autosomal dominant Alzheimer disease: In particular, the details of ADAM10 activation as a function of its structural determinants, prodomain removal and subcellular localization in the secretory pathway are a topic of intense ongoing research, in light of the recent evidence of ADAM10 biological role in tumors and neurodegenerative diseases such as Alzheimer’s disease [10].